US Edition
Published • loading... • Updated
Olbia, the First Medullary Neurostimulation Implant with Ai
Summary by Il Riformista
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
At the Mater Olbia hospital, the first implant was performed in Italy of an innovative high frequency medullary neurostimulation device that uses artificial intelligence for the treatment of chronic pain. It is a latest generation technology belonging to the Nevro line, designed to significantly improve the management of pain in patients suffering from chronic diseases and resistant to traditional treatments. The device, called Nevro HFXiQ, repr…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
